Fundació Hospital Universitari Vall d'Hebron-Institut de Recerca;Fundación Instituto de Investigación Sanitaria Fundación Jiménez Díaz;Universidad Autónoma De Madrid
发明人:
Jesús Egido De Los Ríos,Carmen Gómez Guerrero,Rafael Simó Canonge,Criistina Hernández Pascual
申请号：
US15314395
公开号：
US20170209536A1
申请日:
2015.05.27
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to a SOCS1-derived peptide for use in chronic complications of diabetes, particularly ocular, renal, nerve and vascular complications, as well as compositions containing same and isolated polynucleotides encoding same. The present invention also relates to the SOCS1-derived peptide for topical use in the treatment and/or prevention of neurodegenerative diseases of the retina, particularly in the early stages of diabetic retinopathy and other diseases of the retina in which neurodegeneration plays an essential role.
